Compositions and methods for treatment of microbial infections
AssigneeImmunology Laboratories, Inc.
InventorsJiri Pillich, John Balcarek
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for treatment of microbial infections and for the enhancement of resistance to infection. The invention comprises administration of an effective amount of bacterial lysate compositions for the treatment of pathological conditions of microbial infections. The present invention can also be used to enhance the immune system to prevent infections by the administration of an effective amount of the compositions.
Claims20
A composition, comprising a bacterial lysate derived from the infection of at least one bacterial strain of Staphylococcus aureus (S. aureus), Klebsiella pneumoniae (K. pneumoniae), or Pseudomonas aeruginosa (P. aeruginosa) with a bacteriophage.
A S. aureus bacterial isolate deposited with the CCM under accession number CCM 4992, CCM 4993, CCM 4994, CCM 4995, CCM 4996, CCM 4997, or CCM 4998.
A method of treating pathological conditions of microbial infections in humans or animals comprising administering to a human or animal having a pathological condition a composition comprising a bacterial lysate derived from the infection of at least one bacterial strain of S. aureus, K. pneumoniae or P. aeruginosa with a bacteriophage.
A bacteriophage, deposited with the DSM under accession number DSM 14614, DSM 14615, or DSM 14616.
A method of preventing microbial infections or pathological conditions comprising administering to a human or animal a composition comprising a bacterial lysate derived from the infection of at least one bacterial strain of S. aureus, K. pneumoniae or P. aeruginosa with a bacteriophage.
Dependencies are inferred from the claim text.